Southern Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.46 M
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 5.41%
- Profit Growth -31.39%
- Ebitda 14.34%
- Net Worth 10.75%
- Total Assets -12.56%
About Southern Formulations
Southern Formulations Private Limited (SFPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 May 1995 and has a history of 29 years and nine months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.46 M, as per Ministry of Corporate Affairs (MCA) records.
Geetha Balasimharao and Prasannakumar Thimmappaiah serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232KA1995PTC017729
-
Company No.
017729
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 May 1995
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Southern Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geetha Balasimharao
|
Director | 23-Jun-2003 | Current |
|
Prasannakumar Thimmappaiah
|
Director | 27-Apr-1997 | Current |
Financial Performance of Southern Formulations.
Southern Formulations Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 5.41% increase. The company also saw a substantial fall in profitability, with a 31.39% decrease in profit. The company's net worth Soared by an impressive increase of 10.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Southern Formulations?
In 2017, Southern Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Southern Formulations?
Southern Formulations has a workforce of 15 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Southern Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Southern Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.